Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Terumobct, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

177 daysmedian FDA review time
249 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K183081Spectra Optia Apheresis SystemTerumobct, Inc.2019-02-05910
K181049Spectra Optia Apheresis SystemTerumobct, Inc.2018-11-011950
K172590Spectra Optia Apheresis SystemTerumobct, Inc.2018-03-021850
K162365T-CuffTerumobct, Inc.2017-02-161770
K153601Spectra Optia Apheresis SystemTerumobct, Inc.2016-01-14290
K141938SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA EXCHANGE SET (Terumobct, Inc.2015-03-232490
K132429SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA SYSTEM SOFTWARTerumobct, Inc.2013-12-061230
K131744SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA SINGLE-NEEDLE Terumobct, Inc.2013-08-08560

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda